Skip to main content
SpringerLink
Log in

Bone mineral metabolism and thyroid replacement therapy in congenital hypothyroid infants and young children

  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Impairment of calcium metabolism and low bone density have been found in hypothyroid adults. We investigated the effect of thyroid replacement therapy on calcium metabolism and bone mineralization in congenital hypothyroid (CH) infants and children. One hundred and 16 Caucasian CH consecutive patients were studied and were grouped according to their age: 23 patients at diagnosis, 20 at 3 mo, 24 at 6 mo, 25 at 12 mo and 24 at 36 mo. Thyroid replacement therapy was started at an initial dose of 6–8 μg/kg/day of L-thyroxine, and then decreased progressively. Calcium, phosphorus, magnesium, alkaline phosphatase (AP), parathyroid hormone (PTH) and osteocalcin (BGP) were measured as calcium metabolism indices. Bone mineral content (BMC) was measured at the mid-portion of the right radius AP, PTH and BGP concentrations were significantly higher in subjects at 3 mo of age (p<0.05). This rise coincided with the end of the period of maximum dosage of L-thyroxine. Mild asymptomatic hypercalcemia was observed in 20 patients. All the other indices did not differ between age groups. BMC values and BMC annual increment were not different from those calculated for age-matched controls. We found that L-thyroxine replacement therapy does not alter bone mineralization of CH infants and children. Only a transitory increase of osteoblastic function was observed after the first few months of therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Mosekilde L., Eriksen E.F., Charles P. Effects of thyroid hormones on bone metabolism and mineral metabolism. Endocrinol. Metab. Clin. North Am. 19: 35, 1990.

    PubMed  CAS  Google Scholar 

  2. Bouillon R., Muls E., De Moor P. Influence of thyroid function on the serum concentration of 1,25-dihydroxyvitamin D3. J. Clin. Endocrinol. Metab. 51: 793, 1980.

    Article  PubMed  CAS  Google Scholar 

  3. Krøener B., Jørgensen J.V., Nielsen S.P. Spinal bone mineral content in myxoedema and thyrotoxicosis. Effects of thyroid hormones and antithyroid treatment. Clin. Endocrinol. (Oxf.) 18: 439, 1983.

    Article  Google Scholar 

  4. Melsen F., Mosekilde L. Morphometric and dynamic studies of bone changes in hyperthyroidism. Acta Pathol. Microbiol. Scand. 85: 141, 1977.

    Google Scholar 

  5. Eriksen E.F., Mosekilde L., Melsen F. Trabecular bone remodeling and bone balance in hyperthyroidism. Bone 6: 421, 1985.

    Article  PubMed  CAS  Google Scholar 

  6. Auwerx J., Bouillon R. Mineral and bone metabolism in thyroid disease: a review. Q.J. Med. 232: 737, 1986.

    Google Scholar 

  7. Fraser S.A., Smith D.A., Anderson J.B., Wilson G.M. Osteoporosis and fractures following thyrotoxicosis. Lancet 1: 981, 1975.

    Google Scholar 

  8. Linde J., Friis T. Osteoporosis in hyperthyroidism estimated by photon absorptiometry. Acta Endocrinol. (Copenh.) 91: 437, 1979.

    CAS  Google Scholar 

  9. Toh S.H., Claunch B.C., Brown P.H. Effect of hyperthyroidism and its treatment on bone mineral content. Arch. Int. Med. 145: 883, 1985.

    Article  CAS  Google Scholar 

  10. Campos-Pastor M.M., Muñoz-Torres M., Escobar-Jiménez F., Ruiz de Almodovar M., Jodar Gimeno E. Bone mass in females with different thyroid disorders: influence of menopausal status. Bone Miner. 21: 1, 1993.

    Article  PubMed  CAS  Google Scholar 

  11. Jastrup B., Mosekilde L., Melsen F., Lund Bi., Lund Bj., Sørensen O.H. Serum levels of vitamin D metabolites and bone remodeling in hyperthyroidism. Metabolism 31: 126, 1982.

    Article  PubMed  CAS  Google Scholar 

  12. Campos-Pastor M.M., Muñoz-Torres M., Escobar-Jiménez F., Ruiz de Almodovar M., Jodar Gimeno E. Bone mass in females with different thyroid disorders: influence of menopausal status. Bone Miner. 21: 1, 1993.

    Article  PubMed  CAS  Google Scholar 

  13. Szabo Z.S., Ritzl F. Hypercalcemia in hyperthyroidism — role of age and goiter type. Klin. Wochenschr. 59: 275, 1981.

    Article  PubMed  CAS  Google Scholar 

  14. Parfitt A.M., Dent CE. Hyperthyroidism and hypercalcemia. Q.J. Med. 154: 171,1970.

    Google Scholar 

  15. Macfarlane A., Mawer E.B., Berry J., Hann J. Vitamin D metabolism in hyperthyroidism. Clin. Endocrinol. (Oxf.) 17: 51, 1982.

    Article  CAS  Google Scholar 

  16. Garrel D.R., Delmas P.D., Malaval L., Tourniaare J. Serum bone GLA protein: a marker of bone turnover in hyperthyroidism. J. Clin. Endocrinol. Metab. 62: 1052, 1986.

    Article  PubMed  CAS  Google Scholar 

  17. Lukert B.P., Higgins J.C., Stoskopf M.M. Serum osteocalcin is increased in patients with hyperthyroidism and decreased in patients receiving glucocorticoids. J. Clin. Endocrinol. Metab. 62: 1056, 1986.

    Article  PubMed  CAS  Google Scholar 

  18. Martinez M.E., Herranz L., de Pedro C., Pallardo L.F. Osteocalcin levels in patients with hyper- and hypothyroidism. Horm. Metab. Res. 18: 212, 1986.

    Article  PubMed  CAS  Google Scholar 

  19. Lee M.S., Kim S.Y., Lee M.C., Cho B.Y., Lee M.K., Koh C.-S., MinH.K. Negative correlation between the change in bone mineral density and serum osteocalcin in patients with hyperthyroidism. J. Clin. Endocrinol. Metab. 70: 766, 1990.

    Article  PubMed  CAS  Google Scholar 

  20. Ross D.S. Subclinical hyperthyroidism: possible danger of overzealous thyroxine replacement therapy. Mayo Clin. Proc. 63: 1223, 1988.

    Article  PubMed  CAS  Google Scholar 

  21. Ross D.S., Neer R.M., Ridgway E.C., Daniels G.H. Subclinical hyperthyroidism and reduced bone density as a possible result of prolonged suppression of the pituitary-thyroid axis with L-thyroxine. Am. J. Med. 32: 1167, 1987.

    Article  Google Scholar 

  22. Paul T.L., Kerrigan J., Kelly A.M., Braverman L.E., Baran D.T. Long-term L-thyroxine therapy is associated with decreased hip bone density in premenopausal women. JAMA 259: 3137, 1988.

    Article  PubMed  CAS  Google Scholar 

  23. Ribot C., Tremolliere F., Pouilles J.M., Louvet J.P. Bone mineral density and thyroid hormone therapy. Clin. Endocrinol. (Oxf.) 33: 143, 1990.

    Article  CAS  Google Scholar 

  24. Toh S.H., Brown P.H. Bone mineral content in hypothyroid male patients with hormone replacement: a 3-year study. J. Bone Miner. Res. 5: 463, 1990.

    Article  PubMed  CAS  Google Scholar 

  25. Ross D.S., Ardisson L.J., Nussbaum S.R., Meskell M.J. Serum osteocalcin in patients taking L-thyroxine who have subclinical hyperthyroidism. J. Clin. Endocrinol. Metab. 72: 507, 1991.

    Article  PubMed  CAS  Google Scholar 

  26. Stepán J.J., ’lmanová Z. Biochemical assessment of bone loss on long-term thyroid hormone treatment. Bone Miner. 17: 377, 1992.

    Article  PubMed  Google Scholar 

  27. Tau C., Garabedian M., Farriaux J.P., Czernichow P., Pomarede R., Balsan S. Hypercalcemia in infants with congenital hypothyroidism and its relation to vitamin D and thyroid hormones. J. Pediatr. 109: 808, 1986.

    Article  PubMed  CAS  Google Scholar 

  28. Cameron J.R., Mazess R.B., Sorenson S.A. Precision and accuracy of bone mineral determination by direct photon absorptiometry. Invest. Radiol. 3: 11, 1968.

    Article  Google Scholar 

  29. Steichen J.J., Kaplan B., Edwards N., Tsang R.C. Bone mineral content in full-term infants measured by direct photon absorptiometry. Am. J. Roentgenol. 126: 1283, 1976.

    Article  Google Scholar 

  30. Guarneri M.P., Weber G., Bianchi C., Gallia P., Chiumello G. Bone mineral content in preterm infants at 40 weeks of gestational age. Dev. Physiopath. Clin. 2: 151, 1991.

    Google Scholar 

  31. Greenspan S.L., Greenspan F.S., Resnick N.M., Block J.E., Friedlander A.L., Genant H.K. Skeletal integrity in premenopausal and postmenopausal women receiving long-term L-thyroxine therapy. Am. J. Med. 91: 5, 1991.

    Article  PubMed  CAS  Google Scholar 

  32. Franklyn J.A., Betteridge J., Daykin J., Holder R., Oates G.D., Parle J.V., Lilley J., Heath D.A., Sheppard M.C. Long-term thyroxine treatment and bone mineral density. Lancet 340: 9, 1992.

    Article  PubMed  CAS  Google Scholar 

  33. Ross D.S., Ardisson L.J., Nussbaum S.R., Meskell M.J. Serum osteocalcin in patients taking L-thyroxine who have subclinical hyperthyroidism. J. Clin. Endocrinol. Metab. 72: 507, 1991.

    Article  PubMed  CAS  Google Scholar 

  34. Demeester-Mirkine N., Bergmann P., Body J.J., Corvilain J. Calcitonin and bone mass status in congenital hypothyroidism. Calcif. Tissue Int. 46: 222, 1990.

    Article  PubMed  CAS  Google Scholar 

  35. Fraser W.D., Logue F.C., MacRitchie K., Wilson R.M., Gray H.W., Beastall G.H., O’Reilly D. StJ. Intact parathyroid hormone concentration and cyclic AMP metabolism in thyroid disease. Acta Endocrinol.(Copenh.) 124: 652, 1991.

    CAS  Google Scholar 

  36. Harvey R.D., McHardy K.C., Reid I.W., Paterson F., Bewsher P.D., Duncan A., Robins S.P. Measurement of bone collagen degradation in hyperthyroidism and during thyroxine replacement therapy using pyridinium cross-links as specific urinary markers. J. Clin. Endocrinol. Metab. 72: 1189, 1991.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinica Pediatrica III, Istituto Scientifico H San Raffaele, Università degli Studi di Milano, Italy

    G. Weber, Stefano Mora M.D., M. Bosco, C. Prinster, V. Siragusa, B. di Natale & G. Chiumello

  2. Istituto di Biometria e Statistica Medica, Università degli Studi di Milano, Milano, Italy

    A. Bellini

Authors
  1. G. Weber
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stefano Mora M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Bellini
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Bosco
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. C. Prinster
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. V. Siragusa
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. B. di Natale
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. G. Chiumello
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Weber, G., Mora, S., Bellini, A. et al. Bone mineral metabolism and thyroid replacement therapy in congenital hypothyroid infants and young children. J Endocrinol Invest 18, 277–282 (1995). https://doi.org/10.1007/BF03347813

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03347813

Key-words

Search

Navigation